Navigation Links
Gates Foundation and Mayo Clinic Experts to Address Vaccine Research in the 21st Century

Bethesda, MD (PRWEB) October 23, 2013

Dr. Penny Heaton, Director of Vaccine Development, Global Health Program at the Bill and Melinda Gates Foundation and Dr. Gregory A. Poland, Director, Mayo Vaccine Research Group at the Mayo Clinic will present keynote addresses on global vaccine research and development in the 21st century at the 17th Annual Conference on Vaccine Research, sponsored by the National Foundation for Infectious Diseases (NFID). The conference is scheduled for April 28-30, 2014 in Bethesda, MD.

Vaccines are responsible for the control of many infectious diseases that were once common in this country and around the world, including polio, measles, diphtheria, pertussis (whooping cough), rubella (German measles), mumps, tetanus, and Haemophilus influenzae type b (Hib). Vaccines also eradicated smallpox, one of the most devastating diseases in history, and have prevented countless cases of infectious diseases, saving millions of lives.

According to the Bill and Melinda Gates Foundation, global immunization coverage has never been higher. More than 100 million children are immunized each year, saving an estimated 2.5 million lives. The Global Vaccine Action Plan (GVAP) focuses on making vaccines accessible in the developing world, and supporting vaccine research and development. “All children and their parents should have the same opportunity to receive life-saving vaccines regardless of where they may live,” said Dr. Heaton.

Vaccines of the future may be even more effective. According to Dr. Poland, “vaccines, like drugs and medical procedures, are increasingly amenable to individualization or personalization. As a result of new technologies, 21st century vaccinology will increasingly see the abandonment of a ‘one size fits all’ approach to vaccine dosing and delivery.” Dr. Poland’s work is leading to new understandings of how vaccines stimulate immune responses and which genetic and other factors may affect vaccine response.

NFID’s Annual Conference on Vaccine Research provides high-quality, current reports of scientific progress and best practices in the field of vaccinology, and brings together the diverse disciplines involved in the research and development of vaccines and associated technologies for disease control through immunization. By drawing upon an international audience of scientists and researchers, healthcare professionals and trainees, veterinarians, vaccine manufacturers, and public health officials, the conference is designed to encourage the exchange of ideas across a broad range of disciplines. Topics to be presented include:

  •     Future Trends in Vaccine Research
  •     Current Challenges in Immunization Policy
  •     Vaccines for the Developing World
  •     Regulatory Challenges of Evaluating and Approving Adjuvanted Vaccines
  •     Innovations in Influenza Vaccines
  •     Immunology and Vaccine Discovery

About the National Foundation for Infectious Diseases

Celebrating its 40th anniversary, the National Foundation for Infectious Diseases (NFID) is a non-profit, tax-exempt 501(c)(3) organization founded in 1973 and dedicated to educating the public and healthcare professionals about the causes, treatment, and prevention of infectious diseases. Visit for more information.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Gadgets Made Simple Investigates The Technology Behind AMG Services Bolting Solutions
2. Zamansky LLC Investigates C.R. Bard Inc. On Behalf Of Long-Term Shareholders Over Allegations Related to Vaginal-Mesh Implants
3. Women's Strike Force Announces First Fund Distribution to Virginia House of Delegates Candidates for November Race
4. Allegedly, Fraudulent Marketers Are Joining with Banks to Scam the Elderly; Parker Waichman LLP Investigates a Potential Class Action Lawsuit
5. Sometimes, the Most Evil Things Come from the Most Holy… 3 Gates of the Dead by Jonathan Ryan to be Published by Premier Digital Publishing on October 15, 2013
6. EORTC led intergroup trial investigates Imatinib failure-free survival in patients with GIST
7. Queens University receives Bill and Melinda Gates Foundation grants
8. Gates Fellowship addresses parasite infection in developing world
9. Local San Antonio Research Clinic Investigates New Osteoarthritis Treatments
10. Zamansky & Associates LLC Investigates Chemed Corporation For Possible Securities Law Violations And Breaches Of Fiduciary Duties To Shareholders
11. How is a Latex Mattress Created? The Mattress Geek Investigates in Latest Article
Post Your Comments:
(Date:6/24/2016)... ... 24, 2016 , ... The Pulmonary Hypertension Association (PHA) learned ... receive two significant new grants to support its work to advance research and ... by recognizing patients, medical professionals and scientists for their work in fighting pulmonary ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA is excited ... To Recovery® program to drive cancer patients to and from their cancer treatments. ... highest quality of life and ongoing independence. Getting to and from medical treatments ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Clinical Decision Making in Emergency Medicine conference in Ponte Vedra Beach, FL. The ... published in Emergency Medicine Practice and Pediatric Emergency Medicine Practice. , ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... is actively feeding the Frederick area economy by obtaining investment capital for emerging ... the past 2½ years that have already resulted in more than a million ...
(Date:6/24/2016)... MD (PRWEB) , ... June 24, 2016 , ... ... protocols for human induced pluripotent stem (iPS) cells and other difficult to transfect ... G9™ Cloning Medium. The PluriQ™ G9™ Gene Editing System is a ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Belgium , June 24, 2016 ... the appointment of Dr. Edward Futcher ... Non-Executive Director, effective June 23, 2016.Dr. Futcher was ... Nominations and Governance Committees.  As a non-executive member ... independent expertise and strategic counsel to VolitionRx in ...
(Date:6/23/2016)... June 23, 2016 Any dentist who has made ... the current process. Many of them do not even offer ... difficulties and high laboratory costs involved. And those who ARE ... at such a high cost that the majority of today,s ... Dr. Parsa Zadeh , founder of Dental Evolutions Inc. ...
(Date:6/23/2016)... -- Research and Markets has announced the addition ... - Forecast to 2022" report to their offering. ... to date financial data derived from varied research sources to ... potential impact on the market during the next five years, ... of sub markets, regional and country level analysis. The report ...
Breaking Medicine Technology: